A clinical Study on the Blood Sugar Lowering Effects of Pashanbheda (Bergenia ligulata) in Type 2 Diabetes

Phytochemical and Exploratory Clinical study to evaluate the hypoglycemic effect of Pashanbheda (Bergenia ligulata Wall.) with special reference to Prameha (Diabetes mellitus type 2) - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108840

Enrollment

Registered

2026-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between the age group of 30-70 years, of either sex, with clinical features of Prameha (Diabetes mellitus type2). 2. Patients having a fasting blood sugar level (FBS) greater than 126 mg/dL and less than 200 mg/dL and patients having a 2 hour post prandial blood sugar level (PPBS) greater than 200mg/dL and less than 350 mg/dL. 3. Patients with HbA1c range 6.4 or more. 4. Written consent showing willingness to participate in the study. 5. Freshly diagnosed patient (with no other hypoglycemic treatment).

Exclusion criteria

Exclusion criteria: 1. Patients below the age of 30 years and above 70 years will be excluded. 2. Pregnant and lactating mothers. 3. Known case of Type 1 Diabetes Mellitus or I. D. D. M. Patients are excluded. 4. Type 2 DM patients having insulin therapy due to secondary failure. 5. Patients suffering from the complications of DM like Ketoacidosis, Neuropathy, Nephropathy, Retinopathy and Diabetic wounds. 6. Patients suffering from any severe systemic disease, chronic infections or any active malignancy.

Design outcomes

Primary

Measure	Time frame
Changes in the Objective parameters.Timepoint: 90 days	—

Secondary

Measure	Time frame
Changes in the clinical sign and symptoms of Prameha (Type 2 DM)Timepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Jahanvee gautam

PGIA, DSRRAU, Jodhpur

drmanojarora2503@gmail.com9166639579

Outcome results